Literature DB >> 1320627

A serotype 10 human rotavirus.

G Beards1, L Xu, A Ballard, U Desselberger, M A McCrae.   

Abstract

Rotaviruses with genome rearrangements isolated from a chronically infected immunodeficient child (F. Hundley, M. McIntyre, B. Clark, G. Beards, D. Wood, I. Chrystie, and U. Desselberger, J. Virol 61:3365-3372, 1987) are the first recognized human isolates of serotype 10. This was shown by both a direct enzyme-linked immunosorbent assay and virus neutralization assays using serotype specific monoclonal antibodies. The serotype was confirmed by sequence analysis of the gene encoding VP7, which revealed a 96% amino acid homology to the bovine serotype 10 isolate B223.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320627      PMCID: PMC265305          DOI: 10.1128/jcm.30.6.1432-1435.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  An equine rotavirus (FI-14 strain) which bears both subgroup I and subgroup II specificities on its VP6.

Authors:  Y Hoshino; M Gorziglia; J Valdesuso; J Askaa; R I Glass; A Z Kapikian
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

2.  Heterogeneity of genome rearrangements in rotaviruses isolated from a chronically infected immunodeficient child.

Authors:  F Hundley; M McIntyre; B Clark; G Beards; D Wood; I Chrystie; U Desselberger
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

3.  Production and characterization of neutralizing monoclonal antibody to a human rotavirus strain with a "super-short" RNA pattern.

Authors:  J M Tursi; M J Albert; R F Bishop
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

4.  Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes.

Authors:  K Taniguchi; K Nishikawa; T Urasawa; S Urasawa; K Midthun; A Z Kapikian; M Gorziglia
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.

Authors:  Y Hoshino; M M Sereno; K Midthun; J Flores; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Rotavirus serotypes 6 and 10 predominate in cattle.

Authors:  D R Snodgrass; T Fitzgerald; I Campbell; F M Scott; G F Browning; D L Miller; A J Herring; H B Greenberg
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

7.  Sequence of the gene encoding the major neutralization antigen (VP7) of serotype 10 rotavirus.

Authors:  L Xu; D Harbour; M A McCrae
Journal:  J Gen Virol       Date:  1991-01       Impact factor: 3.891

8.  Human rotavirus strain 69M has a unique VP4 as determined by amino acid sequence analysis.

Authors:  Y Qian; K Y Green
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

9.  Antigenic relationships among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves.

Authors:  G N Woode; N E Kelso; T F Simpson; S K Gaul; L E Evans; L Babiuk
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

10.  Nucleotide sequences of normal and rearranged RNA segments 10 of human rotaviruses.

Authors:  A Ballard; M A McCrae; U Desselberger
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

View more
  23 in total

1.  Diversity in Indian equine rotaviruses: identification of genotype G10,P6[1] and G1 strains and a new VP7 genotype (G16) strain in specimens from diarrheic foals in India.

Authors:  B R Gulati; R Deepa; B K Singh; C Durga Rao
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

2.  Sequence conservation within neutralization epitope regions of VP7 and VP4 proteins of human serotype G4 rotavirus isolates.

Authors:  E A Palombo; R F Bishop; R G Cotton
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998.

Authors:  M Iturriza-Gómara; J Green; D W Brown; M Ramsay; U Desselberger; J J Gray
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Rotavirus serotypes and electropherotypes in Finland from 1986 to 1990.

Authors:  L Maunula; C H von Bonsdorff
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Molecular epidemiology of human rotaviruses in Manipur: genome analysis of rotaviruses of long electropherotype and subgroup I.

Authors:  T Krishnan; B Burke; S Shen; T N Naik; U Desselberger
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.

Authors:  L Padilla-Noriega; R Werner-Eckert; E R Mackow; M Gorziglia; G Larralde; K Taniguchi; H B Greenberg
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Detection of rotavirus serotypes G1, G2, G3, and G11 in feces of diarrheic calves by using polymerase chain reaction-derived cDNA probes.

Authors:  H A Hussein; A V Parwani; B I Rosen; A Lucchelli; L J Saif
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Molecular analysis of the VP7, VP4, VP6, NSP4, and NSP5/6 genes of a buffalo rotavirus strain: identification of the rare P[3] rhesus rotavirus-like VP4 gene allele.

Authors:  V Martella; M Ciarlet; A Pratelli; S Arista; V Terio; G Elia; A Cavalli; M Gentile; N Decaro; G Greco; M A Cafiero; M Tempesta; C Buonavoglia
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Group A rotavirus G type prevalence in two regions of Hungary.

Authors:  G Szücs; D O Matson; M Uj; E Kukán; I Mihály; Z Jelenik; M K Estes
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Serotype analysis of rotaviruses from different locations in Malaysia.

Authors:  N B Rasool; K Y Green; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.